Ets-1 and miR-326 mRNA expression is increased in CD19+ B cells of SLE patients, and miR-326 may be involved in the pathogenesis of SLE by targeting Ets-1 to promote B cell differentiation (75). The gene discussed is ETS1; the disease is systemic lupus erythematosus.